IASIS PHARMA has launched a new pharmaceutical product under the brand name Raberen (as rabeprazole sodium). Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. Raberen in either 10 or 20 mg form of gastro-resistant tablets, is the 1st generic rabeprazole, which has been successfully launched in the Greek pharmaceutical market by a Greek pharmaceutical industry.
RABEREN/ΙΑSIS PRESS RELEASE28/04/2014
ΑVALSAN PLUS PRESS RELEASE10/02/2014